Similar articles

• Biotechnology, patients' rights, and the Moore case.

  Howard JJ. Howard JJ. Food Drug Cosmet Law J. 1989 Jul;44(4):331-58. Food Drug Cosmet Law J. 1989. PMID: 11659209 No abstract available.
• Moore v. Regents of the University of California: expanded disclosure, limited property rights.

  Potts J. Potts J. Northwest Univ Law Rev. 1992 Winter;86(2):453-96. Northwest Univ Law Rev. 1992. PMID: 11659500 No abstract available.
• Controlling conflicts of interest in the doctor-patient relationship: lessons from Moore v. Regents of the University of California.

  Healey JM, Dowling KL. Healey JM, et al. Mercer Law Rev. 1991 Spring;42(3):989-1005. Mercer Law Rev. 1991. PMID: 11651440 No abstract available.
• Conflicts of interest: research and clinical care.

  Morris JC. Morris JC. Alzheimer Dis Assoc Disord. 1994;8(Suppl. 4):49-57. Alzheimer Dis Assoc Disord. 1994. PMID: 11657673 Review.
• Industry reimbursement for entering patients into clinical trials: legal and ethical issues.

  Shimm DS, Spece RG Jr. Shimm DS, et al. Ann Intern Med. 1991 Jul 15;115(2):148-51. doi: 10.7326/0003-4819-115-2-148. Ann Intern Med. 1991. PMID: 2058862 Review.